In order to address the clinical relevance of GILZ–CCL2 axis in human LF, we analyzed GILZ mRNA expression in RNAseq data obtained from NASH and NAFLD patient liver samples63,64. This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatotic liver disease.